In vivo models for screening inhibitors of hepatitis B virus
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 24, 2003
app pub date -
Oct 24, 2002
filing date -
Jun 8, 2001
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention relates to compounds, compositions, and methods for the study, diagnosis, and treatment of disease states related to hepatitis B virus (HBV) replication and gene expression. HBV animal models and methods of use are provided, including methods of screening for compounds and/or potential therapies directed against HBV.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully